BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 24785760)

  • 21. Analysis of anti-depressant potential of curcumin against depression induced male albino wistar rats.
    Chang XR; Wang L; Li J; Wu DS
    Brain Res; 2016 Jul; 1642():219-225. PubMed ID: 26972530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.
    Kraehenmann R; Pokorny D; Vollenweider L; Preller KH; Pokorny T; Seifritz E; Vollenweider FX
    Psychopharmacology (Berl); 2017 Jul; 234(13):2031-2046. PubMed ID: 28386699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chrysin promotes attenuation of depressive-like behavior and hippocampal dysfunction resulting from olfactory bulbectomy in mice.
    Filho CB; Jesse CR; Donato F; Del Fabbro L; Gomes de Gomes M; Rossito Goes AT; Souza LC; Boeira SP
    Chem Biol Interact; 2016 Dec; 260():154-162. PubMed ID: 27818124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission.
    Tokarski K; Bijak M
    Pol J Pharmacol; 1996; 48(6):565-73. PubMed ID: 9112695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of models for spontaneous paroxysmal activity in studies of adaptive changes in serotonin receptors].
    Bobula B; Zahorodna A; Tokarski K; Hess G
    Postepy Hig Med Dosw; 2002; 56(3):377-83. PubMed ID: 12194250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor⁻Receptor Interactions in Multiple 5-HT1A Heteroreceptor Complexes in Raphe-Hippocampal 5-HT Transmission and Their Relevance for Depression and Its Treatment.
    Borroto-Escuela DO; Narváez M; Ambrogini P; Ferraro L; Brito I; Romero-Fernandez W; Andrade-Talavera Y; Flores-Burgess A; Millon C; Gago B; Narvaez JA; Odagaki Y; Palkovits M; Diaz-Cabiale Z; Fuxe K
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29865267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurological mechanism of Xiaochaihutang's antidepressant-like effects to socially isolated adult rats.
    Ma J; Wu CF; Wang F; Yang JY; Dong YX; Su GY; Zhang K; Wang ZQ; Xu LW; Pan X; Zhou TS; Ma P; Song SJ
    J Pharm Pharmacol; 2016 Oct; 68(10):1340-9. PubMed ID: 27524670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs.
    Ogren SO; Fuxe K; Agnati LF; Gustafsson JA; Jonsson G; Holm AC
    J Neural Transm; 1979; 46(2):85-103. PubMed ID: 574536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An animal model of schizophrenia based on chronic LSD administration: old idea, new results.
    Marona-Lewicka D; Nichols CD; Nichols DE
    Neuropharmacology; 2011 Sep; 61(3):503-12. PubMed ID: 21352832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of the amygdala in the effect of antidepressants on olfactory bulbectomised rats.
    Broekkamp CL; Garrigou D; Lloyd KG
    Adv Biochem Psychopharmacol; 1982; 31():371-5. PubMed ID: 6282064
    [No Abstract]   [Full Text] [Related]  

  • 31. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment.
    Keck ME; Sartori SB; Welt T; Müller MB; Ohl F; Holsboer F; Landgraf R; Singewald N
    J Neurochem; 2005 Mar; 92(5):1170-9. PubMed ID: 15715667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.
    Gresch PJ; Barrett RJ; Sanders-Bush E; Smith RL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):662-9. PubMed ID: 17077317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide Trefoil Factor 3 Reverses Depressive-Like Behaviors by Activation of BDNF-ERK-CREB Signaling in Olfactory Bulbectomized Rats.
    Li J; Luo Y; Zhang R; Shi H; Zhu W; Shi J
    Int J Mol Sci; 2015 Nov; 16(12):28386-400. PubMed ID: 26633367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarsasapogenin reverses depressive-like behaviors and nicotinic acetylcholine receptors induced by olfactory bulbectomy.
    Feng B; Zhao XY; Song YZ; Liang WN; Liu JL
    Neurosci Lett; 2017 Feb; 639():173-178. PubMed ID: 27988349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT(2c) antagonist, S32006.
    Norman TR; Cranston I; Irons JA; Gabriel C; Dekeyne A; Millan MJ; Mocaër E
    Eur J Pharmacol; 2012 Jan; 674(1):27-32. PubMed ID: 22040921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT2A/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus.
    Jha S; Rajendran R; Fernandes KA; Vaidya VA
    Neurosci Lett; 2008 Aug; 441(2):210-4. PubMed ID: 18603367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas.
    Hellweg R; Zueger M; Fink K; Hörtnagl H; Gass P
    Neurobiol Dis; 2007 Jan; 25(1):1-7. PubMed ID: 16990008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nelumbinis Semen reverses a decrease in 5-HT1A receptor binding induced by chronic mild stress, a depression-like symptom.
    Jang CG; Kang M; Cho JH; Lee SB; Kim H; Park S; Lee J; Park SK; Hong M; Shin MK; Shim IS; Bae H
    Arch Pharm Res; 2004 Oct; 27(10):1065-72. PubMed ID: 15554266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural pharmacology and therapeutic potential of 5-methoxytryptamines.
    Warren AL; Lankri D; Cunningham MJ; Serrano IC; Parise LF; Kruegel AC; Duggan P; Zilberg G; Capper MJ; Havel V; Russo SJ; Sames D; Wacker D
    Nature; 2024 Jun; 630(8015):237-246. PubMed ID: 38720072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.